Does ROPEGINTERFERON ALFA-2B-NJFT Cause Therapy interrupted? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Therapy interrupted have been filed in association with ROPEGINTERFERON ALFA-2B-NJFT. This represents 1.1% of all adverse event reports for ROPEGINTERFERON ALFA-2B-NJFT.
16
Reports of Therapy interrupted with ROPEGINTERFERON ALFA-2B-NJFT
1.1%
of all ROPEGINTERFERON ALFA-2B-NJFT reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy interrupted From ROPEGINTERFERON ALFA-2B-NJFT?
Of the 16 reports, 1 (6.3%) required hospitalization.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROPEGINTERFERON ALFA-2B-NJFT. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ROPEGINTERFERON ALFA-2B-NJFT Cause?
Fatigue (298)
Off label use (210)
Pruritus (152)
Headache (135)
Inappropriate schedule of product administration (103)
Product dose omission issue (99)
Influenza like illness (97)
Nausea (91)
Diarrhoea (89)
Arthralgia (88)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which ROPEGINTERFERON ALFA-2B-NJFT Alternatives Have Lower Therapy interrupted Risk?
ROPEGINTERFERON ALFA-2B-NJFT vs ROPINIROLE
ROPEGINTERFERON ALFA-2B-NJFT vs ROPIVACAINE
ROPEGINTERFERON ALFA-2B-NJFT vs ROSIGLITAZONE
ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN
ROPEGINTERFERON ALFA-2B-NJFT vs ROSUVASTATIN\ROSUVASTATIN